Protective role of dimethyl diphenyl bicarboxylate (DDB) against erythromycin induced hepatotoxicity in male rats

Toxicology in Vitro

Volumn 21, Issue 4, 2007, Pages 618-625

  Abdel Hameid, Nassr Allah H ^a  

^a BENHA UNIVERSITY   (Egypt)

Author keywords

Biochemical markers; DDB; Erythromycin stearate; Hepatotoxicity; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; DICARBOXYLIC ACID DERIVATIVE; DIMETHYL 4,4' DIMETHOXY 5,6,5',6' DIMETHYLENE DIOXYBIPHENYL 2,2' DICARBOXYLIC ACID; ERYTHROMYCIN STEARATE; GLUCOSE; HEMOGLOBIN; LIPID; SILYMARIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ERYTHROCYTE COUNT; HEMATOCRIT; HEPATOMEGALY; HISTOPATHOLOGY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; RAT; SPLENOMEGALY;

ALANINE TRANSAMINASE; ANIMALS; ANTI-BACTERIAL AGENTS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BODY WEIGHT; CHOLESTEROL; DIOXOLES; ERYTHROMYCIN; HEPATITIS, TOXIC; HEPATOCYTES; LIVER; MALE; NECROSIS; ORGAN SIZE; RATS; SPLEEN;

RATTUS;

EID: 34047253975     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.12.006     Document Type: Article

References (32)

1. Biagini C.P., Boissel E., Borde F., Bender V.E., Bouskila M., Blazy F., Nicaise L., Mignot A., Cassio D., and Chevalier S. Investigation of the hepatotoxicity profile of chemical entities using liverbeads and WIF-B9 in vitro models. Toxicology In Vitro 20 (2006) 1051-1059
2. Chiu P.Y., Tang M.H., Mak D.H., Poon M.K., and Ko K.M. Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins. Free Radical Biology and Medicine 35 (2003) 368-380
3. Cox J.W., Ulrich R.G., Larson P.G., and Gramer C.T. Acute hepatocellular effects of erythromycin, gentamycin and trospectomycin in the perfused rat liver. Pharmacology and Toxicology 62 5 (1988) 337-343
4. Dumas B.T., and Biggs H.G. Standard Methods of Clinical Chemistry vol. 7 (1972), Academic Press, New York
5. Ellefson, R.D., Caraway, W.T., 1976. Fundamentals in clinical chemistry. In: Tietz, N., Saunders, W.B. (Eds.), Philadelphia, pp. 474-541.
6. El-Samaligy M.S., Afifi N.N., and Mahmoud E.A. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. International Journal of Pharmaceutics 319 1-2 (2006) 121-129
7. Hancke J.L., Burgos R.A., and Ahumada F. Schisandra chinensis (Turcz) Bail. Fitotherapia 70 (1999) 451-471
8. Harish R., and Shivanandappa T. Antioxidant activity and hepatoprotective potential of Phyllanthus niruri. Food Chemistry 95 2 (2005) 180-185
9. Helal, A.D., El-Sayed, E.M., Mubuarak, M.G.A., 2003. Using dimethyl diphenyl bicarboxylate (DDB) as antierythromycin hepatotoxicity in goat and rat. In: Third International Scientific Conference at University of Mansoura, pp. 567-582.
10. Henry R.J. Clinical Chemistry (Principles and Techniques) (1964), Harper & Row, New York pp. 181-747
11. Ip S.P., Poom M.K., Wu S.S., Choe C.T., Ng K.H., Kong Y.C., and Ko K.M. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity. Planta Medicine 61 (1995) 398-401
12. Ip S.P., Yiu H.Y., and Ko K.M. Differential effect of schisandrin-B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice. Molecular Cellular Biochemistry 205 1-2 (2000) 111-114
13. Kim S.G., Nam S.Y., Chung H.C., Hong S.Y., and Jung K.H. Enhanced effectiveness of dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate in combination with garlic oil against experimental hepatic injury in rats and mice. Journal of Pharmaceutical Pharmacology 47 (1995) 678-682
14. Kim S.G., Kim H.J., Choi S.H., and Ryu J.Y. Inhibition of lipopolysaccharide-induced I-kappaB degradation and tumor necrosis factor-alpha expression by dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB): minor role of hepatic detoxifying enzyme expression. Liver 20 (2000) 319-329
15. Kim S.C., Cho M.K., and Kim S.G. Cadmium-induced non-apoptotic cell death mediated by oxidative stress under the condition of sulphhydryl deficiency. Toxicology Letter 144 (2003) 325-336
16. Ko K.M., and Lam B.Y. Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutathione antioxidant status in mouse brain. Molecular Cellular Biochemistry 238 (2002) 181-186
17. Lee H.S., Kim Y.T., Jung H.C., Yoon Y.B., Song I.S., and Lim C.Y. Prospective randomized controlled trial with diphenyldimethyldicarboxylate in chronic active liver disease: the effect on lowering serum alanine aminotransferase levels. Korean Journal of International Medicine 40 (1991) 173-178
18. Liu J., Liu Y., and Kalaassen C.D. The effect of Chinese hepatoprotective medicines on experimental liver injury in mice. Journal of Ethnopharmacology 42 3 (1994) 183-191
19. Malloy E., and Evelyn K. The determination of bilirubin with the photoelectric colorimeter. Journal of Biological Chemistry 119 (1937) 481-485
20. NIH guide, 1996. Revised guide for the care and use of laboratory animals. 25(28).
21. Pari L., and Kumar A.N. Hepatoprotective activity of Moringa oleifera on antitubercular drug induced liver damage in rats. Journal of Medicine and Food 5 (2002) 171-177
22. Pari L., and Murugan P. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacological Research 49 5 (2004) 481-486
23. Park E.Y., ki S.H., Ko M.S., Kim C.W., Lee M.H., Lee Y.S., and Kim S.G. Garlic oil and DDB comprised in a pharmaceutical composition for the treatment with viral hepatitis, prevents acute liver injuries potentiated by glutathione deficiency in rats. Chemico-Biological Interactions 155 (2005) 82-96
24. Pessayre D., Larrey D., Brentano F.C., and Benhamon J.B. Drug interaction and hepatitis produced by some macrolide antibiotics. Journal of Antimicrobial Chemotherapy 16 (1985) 181-194
25. Pipkin F.B. Medical Statistics Made Easy (1984), Churchill Livingstone, Edinburgh/London/Melbourne/New York pp. 137
26. Reitman S., and Frankel A.S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. American Journal of Clinical Pathology 28 (1957) 56-63
27. Richard A., and Adams H. Antibiotic induced alteration of cardio-vascular reactivity. Federal Proceeding 35 (1976) 1148-1150
28. Schmit, J.M., 1964. Kits for determination of serum total lipids concentration. Thesis, Lyon.
29. Sivaraman A., Leach J.K., Kownsend S., Iida T., Hogan B.J., Stolz D.B., Fry R., Samson L.D., Tannenbaum S.R., and Griffith L.G. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Current Drug Metabolism 6 23 (2005) 569-591
30. Stein, E.A., 1986. Text book of clinical chemistry. In: Tietz, M.W., Saunders, W.B. (Eds.), Philadelphia, pp. 879-886, 1818-1829.
31. Trinder P. Enzymatic colorimetric method of glucose. Annals Clinical Biochemistry 6 (1969) 24
32. Venkateswaran S., and Pari L. Protective effect of Livex, an herbal formulation against erythromycin estolate induced hepatotoxicity in rats. Journal of Ethnophrmacology 57 (1997) 161-167